Current Health Receives Class II Clearance

NEW YORK and EDINBURGH, Scotland (February 6, 2019)—Current Health, an artificial intelligence (AI)—powered wearable, announced it has received Class II clearance from the U.S. Food and Drug Administration (FDA) for hospital care. Current is a wireless device that continuously monitors patients to help better determine health trajectory to enable clinicians to intervene earlier.

U.S. and U.K. health care providers are deploying Current to change their patient delivery models from reactive to proactive care to produce better patient outcomes. Current’s approach may help health organizations reduce hospital readmissions for patients whose conditions deteriorate after treatment.

Mount Sinai Brooklyn is working with Current to detect patient deterioration earlier and improve health care outcomes. Dr. Scott Lorin, president of Mount Sinai Brooklyn, said, “Current’s continuous and proactive monitoring platform has the potential to alert us to patient deterioration faster and give our team data insights they can act on earlier.”

Current is actively in use with U.K. health care providers in a post-acute setting, including Dartford and Gravesham NHS Trust, which serves a local population of 500,000 people. The

Dartford and Gravesham NHS Trust Hospital at Home team uses Current to remotely monitor patients after discharge. As a result, clinicians and staff reprioritized home visits based on criticality, resulting in a 22 percent reduction in home visits and fewer hospital readmissions and emergency department visits, which freed up skilled nursing time and helped patients feel safe and secure.

“At Current, we’re a small team of individuals committed to changing the world through proactive health care,” said Christopher McCann, CEO of Current. “Our team worked hard to get here, and it’s just the first step toward monitoring the health of every human being to identify sickness earlier with the goal of saving lives. Today, we’re in the hospital, tomorrow the home, and in the near future, we’ll be everywhere. We are just getting started.”

Current is demonstrating its FDA-cleared solution at the HIMSS19 trade show in Orlando from February 11 to 14 at booth 5359-05.

Visit currenthealth.com for more information.